Research & Publications
Clemens W.H. Bergwitz, MD, is an endocrinologist at Yale Medicine who sees patients with primary hyperparathyroidism, general endocrine disorders, hyperthyroidism, thyroid nodules, adrenal disorder, hypophosphatemic disorders and hypogonadism.
Dr. Bergwitz’s characterizes the endocrine system as the human body’s own data messaging system. “It sends information to regulate some of our body’s most critical functions,” he says. In addition to treating patients, Dr. Bergwitz conducts research on many of these conditions, and his lab has worked on projects that test various therapies for hereditary endocrine disorders. “I am really a physician-scientist. My patients inspire my research, which eventually leads back to the bedside,” he says.
Dr. Bergwitz believes that patients should be the expert of their own illness. He strives to explain conditions and treatments in plain language so that patients not only understand their disorder, but also the biological mechanisms behind it. “I’m interested in providing my patients with the information they need to not only understand their condition, but to empower them to take good care of themselves,” he says.
Education & Training
- FellowshipMassachusetts General Hospital (2006)
- ResidencyMassachusetts General Hospital (2003)
- FellowshipNICHD, NIH (2001)
- ResidencyHannover Medical School (1999)
- Research FellowshipMassachusetts General Hospital and Harvard Medical School (1996)
- MDHannover Medical School (1993)
- BAWilhelm Gymnasium, Chemistry and Ancient Greek (1986)
- Advances in FGF23 SignallingBrighton, England, United Kingdom 2019Advances in FGF23 Signaling
- Metabolic and endocrine sensing of phosphate – insights from genetic disordersNantes, Pays de la Loire, France 2017Metabolic and endocrine sensing of phosphate – insights from genetic disorders
- Phosphate Sensing: Two Sensors, a Metabolic and an Endocrine One?Atlanta, GA, United States 2016Phosphate Sensing: Two Sensors, a Metabolic and an Endocrine One?
- Disorders of Phosphate Homeostasis and Tissue MineralizationWürzburg, BY, Germany 2016Disorders of Phosphate Homeostasis and Tissue Mineralization
- Genetic approaches to understanding phosphate homeostasis and Disorders of Phosphate Homeostasis and Tissue MineralizationDresden, SN, Germany 2015Genetic approaches to understanding phosphate homeostasis and Disorders of Phosphate Homeostasis and Tissue Mineralization
- Renal phosphaturia and SLC34A3 mutationsZürich, ZH, Switzerland 2009Renal phosphaturia and SLC34A3 mutations
Honors & Recognition
|Yale Center for Clinical Investigation Pilot on "The impact of phosphate metabolism on healthy aging"||2019|
|O’Brien Center Pilot on “Role of Pyrophosphate in Nephrocalcinosis of Npt2a-/- Mice”||2016, 2017, 2018|
|Young Investigator Award on “Role of the renal sodium-phosphate cotransporter NaPi-IIc in phosphate homeostasis”||American Society for Clinical Investigation||2007|
|Young Investigator Award on “Role of the renal sodium-phosphate cotransporter NaPi-IIc in phosphate homeostasis”||National Kidney Foundation||2007|
|Von-Recklinghausen-Preis||German Endocrine Society||1996|
|Deutsche Forschungsgemeinschaft (DFG)||Ad-hoc Member||2021 - Present|
|French National Research Agency||Ad-hoc reviewer||2021 - Present|
|PRMRP Musculoskeletal health (PRE-MSH-1), Department of Defense||Ad-hoc Member||2020 - Present|
|Research & Development, Pharmaceuticals Pediatric Development, Bayer AG, Berlin, Germany||Advisor||2020 - Present|
|Nature Scientific Reports||Guest Editor||2019 - Present|
|Skeletal Biology Development and Disease (SBDD), NIH||Ad-hoc Member||2017 - Present|